The expression of four genes (HPRT1, CTNS, SHMT1, SLC38A7) was further verified by reverse transcription-polymerase chain reaction (RT–PCR) in patients with HNSCC and in vivo to validate their oncogenic role, and their relationships with the expression of immunological cell markers were also explored. This evidence concerns the gene CTNS and head and neck squamous cell carcinoma.